HA14-1 is Able to Reconstitute the Impaired Mitochondrial Pathway of Apoptosis in Renal Cell Carcinoma Cell Lines

Renal cell carcinomas (RCCs) exhibit a marked resistance towards apoptosis. Although most apoptotic stimuli converge at the level of the mitochondria, little is known about the mitochondrial apoptosis pathway in renal cell carcinomas. The aim of the present study, therefore, was to investigate the functionality of the mitochondrial apoptosis pathway in renal cell carcinoma cell lines by exposure to TRAIL, etoposide, HA14-1 and betulinic acid activating the mitochondria by different mechanisms. Sensitivity to TRAIL-induced apoptosis correlated with cleavage of the initiator caspase-8, but the mitochondrial apoptosis pathway was not induced. Similarly, etoposide and betulinic acid could not induce mitochondrial damage. In contrast, HA14-1 was able to activate mitochondrial apoptosis, thereby demonstrating functionally inducible signalling pathways downstream of the mitochondria. The intactness of the pathways upstream of the mitochondria was shown by pretreatment of TRAIL-sensitive cell lines with HA14-1, which could reconstitute TRAIL-induced mitochondrial damage and resulted in a synergistic apoptosis induction. Our results demonstrate that the apoptotic pathways upstream and downstream of the mitochondria are intact and inducible in renal cell carcinoma cell lines. However, resistance towards mitochondrial apoptosis is located on the level of the mitochondria themselves.

[1]  Jun Peng,et al.  sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell. , 2008, Cancer letters.

[2]  S. Han,et al.  Effect of betulinic acid on anticancer drug-resistant colon cancer cells. , 2007, Basic & clinical pharmacology & toxicology.

[3]  A. Thorburn,et al.  Tumor-derived Mutations in the TRAIL Receptor DR5 Inhibit TRAIL Signaling through the DR4 Receptor by Competing for Ligand Binding* , 2007, Journal of Biological Chemistry.

[4]  C. Xing,et al.  Ethyl-2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H- chromene-3-carboxylate (HA 14-1), a prototype small-molecule antagonist against antiapoptotic Bcl-2 proteins, decomposes to generate reactive oxygen species that induce apoptosis. , 2007, Molecular pharmaceutics.

[5]  C. Mahotka,et al.  Differential gene expression in anticancer drug- and TRAIL-mediated apoptosis in renal cell carcinomas , 2007, Apoptosis.

[6]  Christoph H Emmerich,et al.  TRAIL signalling: decisions between life and death. , 2007, The international journal of biochemistry & cell biology.

[7]  Hyung-Sub Kang,et al.  Reactive oxygen species regulate Bax translocation and mitochondrial transmembrane potential, a possible mechanism for enhanced TRAIL-induced apoptosis by CCCP. , 2007, Oncology reports.

[8]  Donald Wlodkowic,et al.  Larger than life: Mitochondria and the Bcl-2 family. , 2007, Leukemia research.

[9]  Philippe Juin,et al.  Bax activation and mitochondrial insertion during apoptosis , 2007, Apoptosis.

[10]  G. Kroemer,et al.  Apoptosome-Independent Activation of the Lysosomal Cell Death Pathway byCaspase-9 , 2006, Molecular and Cellular Biology.

[11]  C. Scott,et al.  The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. , 2006, Cancer cell.

[12]  W. El-Deiry,et al.  What are caspases 3 and 7 doing upstream of the mitochondria? , 2006, Cancer biology & therapy.

[13]  Keisuke Kuida,et al.  Caspases 3 and 7: Key Mediators of Mitochondrial Events of Apoptosis , 2006, Science.

[14]  J. Houghton,et al.  Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. , 2005, Cancer research.

[15]  M. Tang,et al.  Bcl-2 Rescues Ceramide- and Etoposide-induced Mitochondrial Apoptosis through Blockage of Caspase-2 Activation* , 2005, Journal of Biological Chemistry.

[16]  M. Tang,et al.  Sequential Caspase-2 and Caspase-8 Activation Upstream of Mitochondria during Ceramideand Etoposide-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[17]  I. H. Engels,et al.  Caspase-2 Can Function Upstream of Bid Cleavage in the TRAIL Apoptosis Pathway* , 2004, Journal of Biological Chemistry.

[18]  S. Di Giovanni,et al.  BOK and NOXA Are Essential Mediators of p53-dependent Apoptosis* , 2004, Journal of Biological Chemistry.

[19]  S. Lowe,et al.  Suppression of tumorigenesis by the p53 target PUMA. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Chin,et al.  p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Häcker,et al.  Functional evaluation of the apoptosome in renal cell carcinoma , 2003, British Journal of Cancer.

[22]  Wafik S El-Deiry,et al.  TRAIL and apoptosis induction by TNF-family death receptors , 2003, Oncogene.

[23]  Andreas Villunger,et al.  p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa , 2003, Science.

[24]  M. V. Heiden,et al.  Caspase-9 is activated in a cytochrome c-independent manner early during TNFα-induced apoptosis in murine cells , 2003, Cell Death and Differentiation.

[25]  J. Tan,et al.  HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death , 2003, Leukemia.

[26]  C. Gerharz,et al.  Apoptosis induction in renal cell carcinoma by TRAIL and γ-radiation is impaired by deficient caspase-9 cleavage , 2003, British Journal of Cancer.

[27]  F. Beguinot,et al.  Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Death-inducing Signaling Complex and Its Modulation by c-FLIP and PED/PEA-15 in Glioma Cells* , 2002, The Journal of Biological Chemistry.

[28]  H. S. Kim,et al.  Inactivating mutations of KILLER/DR5 gene in gastric cancers. , 2001, Gastroenterology.

[29]  C. Gerharz,et al.  Topotecan (Hycamtin) responsiveness in human renal carcinoma cell lines of the clear cell and papillary types. , 2001, Anticancer research.

[30]  J. Martinou,et al.  Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. , 2001, Molecular cell.

[31]  T. Rebbeck,et al.  Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  Colin Adrain,et al.  Executioner Caspase-3, -6, and -7 Perform Distinct, Non-redundant Roles during the Demolition Phase of Apoptosis* , 2001, The Journal of Biological Chemistry.

[33]  Erwin G. Van Meir,et al.  Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. , 2001, Cancer research.

[34]  C. Gerharz,et al.  Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan , 2000, Cell Death and Differentiation.

[35]  Xiaodong Wang,et al.  Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.

[36]  Robert L Moritz,et al.  Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins , 2000, Cell.

[37]  S. Srinivasula,et al.  Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  E. Slee,et al.  Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release , 2000, Cell Death and Differentiation.

[39]  P. Krammer,et al.  Deficient activation of CD95 (APO-1/ Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma , 2000, British Journal of Cancer.

[40]  Ingo Schmitz,et al.  Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells* , 1999, The Journal of Biological Chemistry.

[41]  G. Condorelli,et al.  PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis , 1999, Oncogene.

[42]  I. Jeremias,et al.  Betulinic acid: A new cytotoxic agent against malignant brain‐tumor cells , 1999, International journal of cancer.

[43]  P. Nicotera,et al.  1-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis. , 1998, Molecular pharmacology.

[44]  M. Peter,et al.  Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. , 1997, Cancer research.

[45]  Margot Thome,et al.  Inhibition of death receptor signals by cellular FLIP , 1997, Nature.

[46]  S. Störkel,et al.  Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro. , 1993, The American journal of pathology.

[47]  R. Lewontin.  Larger than life , 1985, Nature.

[48]  Min Chen,et al.  Delineation of the caspase-9 signaling cascade , 2007, Apoptosis.

[49]  D. Golde,et al.  Caspase-8 dependent trail-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase , 2006, Apoptosis.

[50]  John Calvin Reed,et al.  FLIP protein and TRAIL-induced apoptosis. , 2004, Vitamins and hormones.

[51]  R. Moll,et al.  Cytomorphological, cytogenetic, and molecular biological characterization of four new human renal carcinoma cell lines of the clear cell type , 2004, Virchows Archiv.